Header Logo

Connection

Kenneth Boyer to Toxoplasmosis, Congenital

Back to Details
This is a "connection" page, showing publications Kenneth Boyer has written about Toxoplasmosis, Congenital.
Kenneth Boyer
Connection Strength
1.894
Toxoplasmosis, Congenital
  1. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis. 2011 Dec; 53(11):1081-9.
    View in: PubMed
    Score: 0.416
  2. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol. 2005 Feb; 192(2):564-71.
    View in: PubMed
    Score: 0.261
  3. Diagnostic testing for congenital toxoplasmosis. Pediatr Infect Dis J. 2001 Jan; 20(1):59-60.
    View in: PubMed
    Score: 0.197
  4. Diagnosis and treatment of congenital toxoplasmosis. Adv Pediatr Infect Dis. 1996; 11:449-67.
    View in: PubMed
    Score: 0.139
  5. Patterns of Hydrocephalus Caused by Congenital Toxoplasma gondii Infection Associate With Parasite Genetics. Clin Infect Dis. 2015 Dec 15; 61(12):1831-4.
    View in: PubMed
    Score: 0.137
  6. Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clin Infect Dis. 2012 Jun; 54(11):1595-605.
    View in: PubMed
    Score: 0.107
  7. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One. 2008 Jun 04; 3(6):e2285.
    View in: PubMed
    Score: 0.082
  8. Cataracts in congenital toxoplasmosis. J AAPOS. 2007 Dec; 11(6):551-4.
    View in: PubMed
    Score: 0.079
  9. Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology. 2008 Mar; 115(3):553-559.e8.
    View in: PubMed
    Score: 0.078
  10. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics. 2006 Aug; 118(2):e379-90.
    View in: PubMed
    Score: 0.072
  11. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006 May 15; 42(10):1383-94.
    View in: PubMed
    Score: 0.071
  12. The child with congenital toxoplasmosis. Curr Clin Top Infect Dis. 2000; 20:189-208.
    View in: PubMed
    Score: 0.046
  13. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology. 1996 May; 199(2):433-40.
    View in: PubMed
    Score: 0.036
  14. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics. 1995 Jan; 95(1):11-20.
    View in: PubMed
    Score: 0.032
  15. Congenital toxoplasmosis. The Toxoplasmosis Study Group. Semin Pediatr Neurol. 1994 Sep; 1(1):4-25.
    View in: PubMed
    Score: 0.032
  16. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994 Jan; 18(1):38-72.
    View in: PubMed
    Score: 0.030
  17. Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group. Antimicrob Agents Chemother. 1992 May; 36(5):1040-8.
    View in: PubMed
    Score: 0.027
  18. Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis. Otolaryngol Head Neck Surg. 1992 Jan; 106(1):75-80.
    View in: PubMed
    Score: 0.026
  19. Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J Lab Clin Med. 1990 Nov; 116(5):623-35.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.